---

Answers to Community Medicine Long Essay Questions (Q14–Q26)

---

Q14. Cohort Study: Obesity and Hypertension [DMGMCH]

• The exposure (obesity) is identified first, before disease develops
• Study proceeds from cause → effect
• Incidence of disease is measured in both exposed and unexposed groups

---

Steps of a Cohort Study

1. Define the study population (cohort): Select adult males aged 25-30 years without hypertension at baseline. Here: 2000 obese + 4000 non-obese = 6000 individuals.
2. Assess and confirm exposure status: Classify individuals into exposed (obese: BMI ≥30) and unexposed (non-obese: BMI <30) at the start using standard criteria (BMI, waist circumference). Ensure all are free of hypertension at baseline.
3. Baseline data collection: Record demographic data, diet, physical activity, family history, alcohol use, smoking, and other potential confounders.
4. Follow-up: Observe both groups for 15 years with periodic assessments (e.g., annual BP measurement, weight monitoring). Minimize loss to follow-up.
5. Identify the outcome: Record new cases of hypertension (defined as SBP ≥140 and/or DBP ≥90 mmHg on two separate occasions, or on antihypertensive treatment) during follow-up.
6. Analysis and interpretation: Calculate rates, relative risk, attributable risk, etc.

---

Advantages

• Establishes temporal sequence (exposure precedes disease) - stronger causal evidence
• Allows calculation of incidence rates and Relative Risk (RR) directly
• Can study multiple outcomes from a single exposure
• Less prone to selection bias and recall bias
• Can observe natural history of disease

Disadvantages

• Expensive and time-consuming (15 years here)
• Losses to follow-up can bias results
• Not suitable for rare diseases
• Exposure status may change over time (people may lose or gain weight)
• Risk of Neyman bias (survivor bias)
• Requires large sample sizes

---

Analysis of Study Findings

• Among obese: 200/2000 = 10% (0.10)
• Among non-obese: 100/4000 = 2.5% (0.025)

• The risk of hypertension attributable to obesity is 7.5 per 100 persons.

• 75% of hypertension in obese individuals is attributable to obesity.

---

Q15. Modes of Disease Transmission [CNMCH]

Modes of Disease Transmission (Enumeration)

1. Direct contact (touching, kissing, sexual intercourse)
2. Droplet infection (coughing/sneezing within 1 metre)
3. Transplacental (vertical) - e.g., rubella, syphilis, HIV

1. Vehicle-borne (water, food, milk, biological products, fomites)
2. Vector-borne (mechanical, biological)
3. Airborne (droplet nuclei, dust, spores)

---

Indirect Disease Transmission (Detailed)

1. Vehicle-borne Transmission

• Water-borne: Contaminated water transmits cholera (Vibrio cholerae), typhoid (Salmonella typhi), dysentery, hepatitis A. Example: A contaminated municipal water supply causing a cholera outbreak.
• Food-borne: Contaminated/inadequately cooked food transmits Salmonella, Staphylococcal enterotoxin, brucellosis (raw milk), hepatitis E (pork). Example: Salmonella food poisoning from contaminated chicken.
• Fomite-borne: Inanimate objects such as clothing, bedding, toys, surgical instruments. Example: Improperly sterilized surgical instruments transmitting hepatitis B.
• Blood/biological products: HIV, hepatitis B/C through transfusion or needle sharing.

2. Vector-borne Transmission

• Example: Housefly mechanically transmitting Salmonella typhi from faeces to food.

• Examples:
  • Anopheles mosquito + Plasmodium (malaria) - both multiplication and development occur
  • Culex mosquito + Wuchereria bancrofti (filariasis) - developmental cycle
  • Female Aedes aegypti + Dengue virus
  • Ixodes tick + Borrelia burgdorferi (Lyme disease)

3. Airborne Transmission

• Examples: Tuberculosis (M. tuberculosis on droplet nuclei), measles, chickenpox, Q fever (Coxiella via dust), COVID-19 (aerosol).

---

Importance of Incubation Period in Epidemiological Studies

1. Identifies the causative agent: The length of incubation period suggests the likely pathogen. Short IP (1-6 hrs) → Staphylococcal toxin; 1-2 days → cholera; 2-4 weeks → hepatitis A.
2. Determines the period of exposure: In a point-source outbreak, knowing the IP allows back-calculation of the likely time and source of exposure. The epidemic curve + IP identifies the common vehicle (e.g., feast, contaminated well).
3. Determines the quarantine/isolation period: The quarantine period for contacts equals the maximum incubation period of the disease (e.g., 21 days for smallpox, 14 days for COVID-19).
4. Helps trace contacts: By knowing the IP, all contacts during the period of communicability can be traced and monitored.
5. Determines secondary attack rate: Secondary cases occurring within one incubation period after the index case can be counted, helping calculate secondary attack rate.
6. Distinguishes point-source from propagated outbreak: In a point-source outbreak, all cases occur within one incubation period. A propagated epidemic shows cases spread over multiple IPs.
7. Assesses effectiveness of control measures: If no new cases appear after one IP of implementing control, the intervention is considered successful.

---

Q16. Modes of Transmission and Biological Transmission [CMSDH]

Modes of Transmission (Enumerated)

1. Direct contact (skin-to-skin, mucous membrane contact)
2. Droplet spread (large droplets, <1 metre)
3. Vertical/transplacental (mother to fetus)
4. Contact with soil (tetanus, hookworm)

---

Biological Transmission (Outline with Examples)

• Malaria: Plasmodium vivax undergoes sexual cycle (sporogony) in the Anopheles mosquito. Sporozoites are injected into humans through the bite.
• Dengue: Dengue virus propagates in Aedes aegypti; transovarial transmission also possible.
• Filariasis: Microfilariae from human blood are ingested by Culex mosquito, develop to infective L3 larvae in flight muscles, and are deposited on skin during subsequent bite.
• Kala-azar (Leishmaniasis): Leishmania donovani develops in sandfly (Phlebotomus).

---

Strategies to Prevent Transmission of Infectious Diseases

1. Source control: Isolation and treatment of cases; quarantine of contacts; treatment of carriers.
2. Breaking the chain of transmission:
   • Disinfection of water and food (chlorination, pasteurization)
   • Vector control (insecticides, larvicides, bed nets, IRS)
   • Use of PPE (gloves, masks, condoms)
   • Hand hygiene (reduces direct and vehicle transmission)
3. Host protection:
   • Immunization (active and passive)
   • Chemoprophylaxis (e.g., antimalarials for travellers)
4. Environmental sanitation:
   • Safe water supply, sanitary sewage disposal, food safety regulations
5. Health education and behavioral change

---

Q17. Cohort Study for Screen Time and Mental Disorders [CMSDH]

Most Appropriate Study: Prospective Cohort Study

• The exposure (screen time in early childhood) precedes the outcome (mental disorders in adolescence) by years
• Temporal sequence can be established
• Multiple mental health outcomes can be studied
• Incidence of mental disorders in high vs. low screen time groups can be compared

---

Steps to Conduct the Study

1. Define research question and hypothesis: "Does high screen time in early childhood (ages 2-5 years) increase the risk of common mental disorders (CMD) in adolescence (ages 10-18 years)?"
2. Study population: Children aged 2-5 years enrolled from schools/community centres. Sample size calculation based on expected prevalence of CMD, RR, alpha error (0.05), power (80%).
3. Assess exposure at baseline:
   • Measure daily screen time (TV, tablets, phones) in hours using parental questionnaire and structured diary
   • Categorize: low (<1 hr/day), moderate (1-3 hrs/day), high (>3 hrs/day) per WHO/AAP guidelines
   • Record potential confounders: socioeconomic status, parental mental health, physical activity, sleep hours, family environment.
4. Follow-up: Follow cohort until participants reach adolescence (10-18 years). Assess screen time at regular intervals (every 2 years) as exposure may change.
5. Assess outcome:
   • Diagnose CMD (depression, anxiety, ADHD, conduct disorder) using validated tools (DASS-21, SDQ - Strengths and Difficulties Questionnaire, DSM-5 criteria) administered by trained psychologists at adolescence.
6. Analysis:
   • Calculate incidence of CMD in each screen time group
   • Calculate Relative Risk (RR) and 95% CI
   • Multivariate logistic/Cox regression to adjust for confounders
   • Dose-response relationship: assess if more screen time correlates with higher CMD risk
7. Interpretation:
   • RR >1 with CI not crossing 1 → significant positive association
   • Apply Bradford Hill criteria for causality

---

Most Common Biases and Methods to Address Them

• Problem: Parents may over/under-report screen time (recall error; social desirability bias).
• Solution: Use objective measures (parental logbooks, screen-time tracking apps, accelerometers); validate self-reports against objective data.

• Problem: Over 10-15 years, significant dropout may occur; those who drop out may differ from those who remain.
• Solution: Regular follow-up visits, incentives, tracking through schools; perform intention-to-treat analysis and sensitivity analysis.

• Problem: Socioeconomic status, parental mental illness, sleep deprivation, peer relationships all affect CMD independently.
• Solution: Measure all known confounders at baseline; use multivariable analysis, propensity score matching, or restriction.

---

Q18. Case-Control Study for a Rare Disease Associated with Smoking [BSMCH]

Most Appropriate Study: Case-Control Study

• Need an extremely large cohort to accumulate sufficient cases
• Disease is fatal, so follow-up is difficult
• Would require decades of observation

• Rare diseases
• Fatal diseases (cases can be identified before death or from records)
• Quick and inexpensive

---

Steps to Conduct a Case-Control Study

1. Define the hypothesis: "Smoking is associated with [rare fatal disease X]."
2. Define and select cases:
   • Establish clear diagnostic criteria (e.g., histologically confirmed)
   • Select incident (newly diagnosed) cases from hospitals, cancer registries, death certificates
   • Eligibility criteria: age, sex, residence - specified and applied consistently.
3. Select controls:
   • Same age, sex, and neighbourhood as cases (matched controls)
   • Must not have the disease under study
   • Sources: hospital controls (other ward patients), neighbourhood controls, or population-based controls
   • Match on important confounders (age, sex, socioeconomic status)
   • Ratio: 1 case : 2-4 controls to increase power (especially since cases are rare)
4. Measure exposure (smoking history):
   • Interview cases and controls using a structured questionnaire
   • Ask about: smoking status, duration, quantity (pack-years), type of tobacco
   • Interviewer should be blinded to case/control status to prevent interviewer bias
   • Supplement with medical records where available
5. Control confounding:
   • Collect data on all potential confounders (age, occupation, alcohol, diet, occupational exposures)
   • Apply matching during design phase; use stratification or multivariate analysis during analysis
6. Analysis:
   • Construct a 2×2 table
   • Calculate Odds Ratio (OR) as approximation of RR (valid when disease is rare - rare disease assumption)
   • OR = (a×d)/(b×c)
   • Apply chi-square test; calculate 95% CI for OR
   • OR >1 with CI not crossing 1 = statistically significant association
7. Interpretation and conclusion: If OR is significantly >1, conclude that smoking is associated with the disease.

---

Advantages of Case-Control Study

1. Suitable for rare diseases - cases already exist
2. Quick and inexpensive - no long follow-up
3. Can study multiple exposures (risk factors) for a single disease
4. Small sample size required compared to cohort
5. No risk to participants
6. Can be used for diseases with long latent periods

Disadvantages

1. Recall bias - cases may remember past exposures more vividly than controls
2. Selection bias in choosing controls (difficult to get appropriate controls)
3. Cannot calculate incidence rates or true Relative Risk - only Odds Ratio
4. Cannot study rare exposures efficiently
5. Temporal sequence is not always established
6. Susceptible to confounding
7. Not suitable when exposure data from the past is unavailable or unreliable
8. Berkson's bias if hospital controls used

---

Q19. Cross-Sectional Study for Prevalence of Obesity Among Medical Students [BSMCH]

Type and Design of Study

• The objective is to determine prevalence (not incidence or causation)
• Both exposure and outcome are measured at the same point in time
• Available time frame is 3 months - too short for cohort/case-control
• Simple, quick, inexpensive, feasible within institution

---

Steps of the Cross-Sectional Study

• Define objectives clearly: "To determine prevalence of obesity among medical students of [institution] and its associated factors"
• Get ethical committee approval
• Prepare study protocol, informed consent form, and study proforma

• All MBBS students (all years/batches) enrolled at the institution
• Define inclusion criteria: Currently enrolled MBBS students aged 18-25 years
• Exclusion criteria: Students with chronic illnesses that affect weight (thyroid disease, Cushing's syndrome), pregnant students, those unwilling to consent.

• Calculate sample size using formula: n = Z²pq/d²
  • Assume expected prevalence (p) = 20% (0.2), d = 5% absolute precision, Z = 1.96
  • n ≈ 246 students
• Sampling method: Stratified random sampling by year of study (Phase 1, 2, 3 Part 1, 3 Part 2), then simple random sampling within each year to ensure representation.

• Anthropometric measurements:
  • Weight (kg) using calibrated weighing scale; height (cm) using stadiometer
  • Calculate BMI = Weight (kg) / Height (m²)
  • Waist circumference with tape measure
• Classify obesity: BMI ≥25 kg/m² (overweight), ≥30 kg/m² (obese) as per WHO; or using Asia-Pacific cut-offs (BMI ≥23 overweight, ≥27.5 obese for South Asians)
• Questionnaire data: Dietary habits (24-hour dietary recall), physical activity (IPAQ), screen time, sleep hours, family history of obesity, socioeconomic status, year of study, hostel/day-scholar status, stress (PSS scale)

• Test proforma on 10% of sample; revise for clarity and feasibility.

• Trained investigators conduct measurements
• Maintain confidentiality
• Complete data collection within 6-8 weeks

• Enter data in SPSS/Epi Info
• Calculate prevalence of obesity (obese/total × 100)
• Frequencies and percentages for categorical variables; mean ± SD for continuous
• Chi-square test to find associations between obesity and lifestyle/dietary factors
• Logistic regression for independent predictors of obesity

• Prepare report with findings, tables, bar charts
• Present to institution; recommend interventions (canteen policy, exercise programs, awareness campaigns)

---

Q20. Outbreak Investigation: Acute Watery Diarrhoea [BGMCH]

Steps to Investigate the Outbreak

1. Confirm the existence of an outbreak:
   • Verify that the number of diarrhoea cases exceeds the expected baseline (endemic level) for this season and locality.
   • Confirm diagnosis by clinical history (acute watery diarrhoea, severe dehydration).
2. Establish a case definition:
   • Example: "Any person residing in village X who developed ≥3 loose/watery stools per day between [date range], with or without dehydration."
   • Apply case definition uniformly.
3. Case finding and line listing:
   • Actively search for cases: door-to-door survey, PHC records, ASHA reports
   • Prepare a line list: name, age, sex, address, onset date, symptoms, exposure history (food/water source), outcome (alive/dead).
4. Descriptive epidemiology (Person, Place, Time):
   • Person: Age/sex distribution, common exposures (community feast, shared water source)
   • Place: Map cases; identify clustering around water sources, households
   • Time: Plot epidemic curve to determine point-source vs. propagated outbreak
5. Generate hypothesis:
   • Based on descriptive data, identify likely source and mode of transmission
   • Hypothesis: "Contamination of the village hand pump / open well is the source of infection."
6. Test hypothesis:
   • Analytical study: Case-control study - compare food/water exposures in cases vs. age/sex-matched controls from the same village
   • Laboratory investigation: Stool samples from cases (culture for Vibrio cholerae, E. coli, Shigella); water samples from suspected sources (coliform count, presence of pathogens)
   • Environmental inspection of water sources, latrines, drainage
7. Implement immediate control measures:
   • ORS distribution, IV fluids for severe dehydration
   • Chlorination of water sources (1 mg/L residual)
   • Food safety: ban on community feasts pending investigation
   • Proper disposal of excreta; disinfection of contaminated areas
8. Evaluate control measures and prepare an outbreak report for CMOH/Health Department.

---

Attack Rate

Attack Rate = (Number of new cases / Population at risk) × 100

• Total village population = 1,500
• Cases = 45

---

Environmental Sanitation Plan

1. Emergency chlorination of all drinking water sources (hand pumps, wells) to achieve residual chlorine of 0.5 mg/L at point of use
2. Prohibit use of contaminated water source until tested safe
3. Supply of safe drinking water (tankers, bottled water, ORS) to affected households
4. Promote household water treatment (boiling, chlorination tablets, ORP - oral rehydration packets)
5. Establish temporary sanitation facilities (portable toilets) to prevent open defecation
6. Safe disposal of diarrhoeal excreta (deep burial, lime treatment)
7. Health education through ASHA, ANM, Gram Panchayat

1. Construct/repair piped water supply with regular chlorination and bacteriological testing
2. Eliminate open defecation - construction of household toilets under Swachh Bharat Mission
3. Install sewage disposal system to prevent contamination of water sources
4. Food hygiene regulations for community feasts (food handler training, inspection)
5. Community education on hand hygiene (soap-and-water handwashing at 5 critical moments)
6. Bacteriological surveillance of water sources (quarterly testing)
7. Strengthen cold chain and vaccine coverage (Rotavirus vaccine under NIS)
8. Train ASHA/ANM for early detection and reporting of diarrhoeal outbreaks

---

Q21. Epidemiology - Definition, Classification, Cohort Steps, Bias [MCK]

Definition of Epidemiology

• Distribution: Who gets the disease (person), where (place), when (time)
• Determinants: Causes and risk factors
• Application: Prevention and control

---

Classification of Epidemiological Studies

1. Descriptive: Describe distribution of disease by person, place, time. E.g., cross-sectional surveys, case reports, case series, ecological studies.
2. Analytical:
   • Case-Control Study (retrospective)
   • Cohort Study (prospective/retrospective)

1. Randomized Controlled Trial (RCT) - clinical trial
2. Community trial (field trial) - e.g., vaccine trials in community
3. Natural experiments

---

Steps of a Cohort Study

1. Define the study cohort from the target population (e.g., workers exposed to a chemical, or a defined community)
2. Measure exposure at baseline - classify into exposed and unexposed groups; ensure all participants are disease-free at start
3. Record baseline characteristics - age, sex, lifestyle, confounders
4. Follow up both groups over time with periodic examinations
5. Identify new cases (outcome/disease) in both groups during follow-up

• Calculate incidence in exposed and unexposed
• Calculate Relative Risk (RR) = Incidence in exposed / Incidence in unexposed
• Calculate Attributable Risk, Population Attributable Risk

---

Biases Associated with Cohort Study

1. Selection bias: Non-representative sampling; healthy worker effect (workers appear healthier than general population because severely ill people don't work)
2. Attrition/Loss to follow-up bias: Those who drop out may differ systematically from those who remain
3. Information/Measurement bias: Differential surveillance of exposed vs. unexposed; ascertainment bias
4. Confounding: Unmeasured or residual confounders affect the association

---

Q22. Case-Control Study: Obesity and Osteoarthritis [PCSGMCH]

Design of Case-Control Study

• Cases: Patients aged 35-65 years diagnosed with radiologically confirmed OA of the knee (Kellgren-Lawrence grade ≥2 on X-ray) attending orthopaedic OPD/hospital
• Controls: Age (±5 years) and sex-matched individuals without OA knee, from same hospital (other departments) or community
• Ratio: 1 case : 2 controls (for increased statistical power)

• Cases: Age 35-65, bilateral or unilateral OA knee, willing to participate; Exclude: inflammatory arthritis (RA, gout), secondary OA, previous knee surgery/trauma
• Controls: Same age/sex, no OA knee, no hip OA or other joint disease; same exclusions

• Match on age (±5 years), sex, and residence (urban/rural) to control confounding by these variables

• Measure BMI (weight/height²) at time of interview
• Also collect lifetime weight history (retrospective) to assess past obesity
• Classify: Normal (BMI <23), Overweight (23-27.4), Obese (≥27.5) per Asian cut-offs
• Additional exposures: occupational physical activity, sports history, diet (Vitamin D, calcium), family history of OA

• Structured pre-tested questionnaire administered by trained interviewer
• Blinding: interviewer should be unaware of case/control status (interviewer blinding reduces interviewer bias)

• 95% CI for OR
• Multivariate conditional logistic regression adjusting for confounders

---

Advantages of Case-Control Study

1. Suitable for rare diseases (OA is not rare, but design is ideal for rare conditions)
2. Quick and inexpensive - no long follow-up needed
3. Can study multiple risk factors simultaneously (obesity, diet, physical activity, occupation)
4. Useful for diseases with long latent periods
5. Requires smaller sample size than cohort

Disadvantages

1. Recall bias - cases may remember past obesity more than controls
2. Selection bias in choosing appropriate controls
3. Only Odds Ratio calculable - not true incidence rates
4. Cannot prove temporal sequence definitively

---

Biases in Case-Control Studies

1. Recall bias (Information bias): Cases (who have disease) may recall past exposures (obesity history) more completely or differently than controls. Mitigation: Use medical records, photographs, objective measurements.
2. Selection bias: The way cases or controls are selected may introduce systematic error. Berkson's bias occurs when hospital controls differ from general population. Mitigation: Use population-based controls; multiple control groups.
3. Interviewer bias: If the interviewer knows who is a case, they may probe more deeply for exposure history. Mitigation: Blind interviewers to case/control status.

---

Q23. Dengue Fever - Diagnosis, Management, and BMOH Steps [PCSGMCH]

Diagnosis

• High-grade fever for 5 days
• Retro-orbital pain, headache (classic dengue features)
• Bleeding gums, petechial rash (hemorrhagic manifestations)
• Pain abdomen (may indicate plasma leakage)
• Tachycardia (PR 120/min), hypotension (BP 90/60 mmHg) → dengue shock
• Cluster of fever cases in locality suggests epidemic transmission

1. CBC: Look for thrombocytopenia (<1,00,000/µL), hemoconcentration (PCV >20% rise from baseline), leukopenia
2. Dengue NS1 antigen (days 1-5 of fever) - rapid bedside test
3. Dengue IgM/IgG antibodies (from day 5 onwards) - MAC-ELISA
4. RT-PCR for dengue serotyping (at district/reference lab)
5. Liver function tests (raised AST/ALT common in dengue)
6. Coagulation profile: PT, aPTT (if hemorrhage is severe)
7. Blood glucose, urea, creatinine, electrolytes
8. Chest X-ray / ultrasound abdomen: pleural effusion, ascites (plasma leakage)

---

Management

1. IV access - two large-bore IV lines
2. Fluid resuscitation: Crystalloid (Normal Saline or Ringer's Lactate) 10-20 mL/kg as bolus over 15-30 minutes; reassess vitals and repeat if shock persists
3. Monitor: HR, BP, urine output (target >0.5 mL/kg/hr), PCV every 2-4 hours
4. If no improvement with crystalloids: colloid (Dextran/HES) cautiously
5. Platelet transfusion: Only if platelet <10,000/µL with active bleeding or <20,000/µL before invasive procedure
6. Fresh Frozen Plasma if significant coagulopathy
7. Antipyretics: Paracetamol only (NO aspirin, NSAIDs - increase bleeding risk)
8. Avoid: Steroids (not proven beneficial); avoid unnecessary IV fluids (risk of pulmonary edema in recovery phase)
9. Oxygen supplementation if SpO₂ <95%
10. Barrier nursing and mosquito net (prevent nosocomial transmission to Aedes mosquitoes)
11. Notify in IDSP case reporting form (P form) immediately

---

Steps Taken by BMOH (Block Medical Officer of Health)

1. Verification and notification: Confirm the case as a probable/confirmed dengue case; notify CMOH and IDSP immediately as per Integrated Disease Surveillance Programme (IDSP) protocol (P-form within 24 hours for outbreak-prone diseases).
2. Outbreak investigation team: Constitute a Rapid Response Team (RRT) - BMOH, PHC MO, sanitarian, entomologist - to investigate the cluster of fever cases.
3. Epidemiological investigation: Conduct house-to-house survey in the affected locality; prepare line list of all fever cases; draw epidemic curve to determine extent of outbreak.
4. Entomological survey: House Index (HI), Container Index (CI), Stegomyia (Breteau) Index assessed. Identify mosquito breeding sites (water storage containers, tyres, flower pots, construction sites).
5. Vector control operations:
   • Source reduction: Remove/drain all water-holding containers; cover water storage; fill pits/puddles
   • Larviciding: Application of Temephos (Abate) to water containers that cannot be emptied
   • Fogging/space spraying: Malathion/Pyrethroid ULV fogging in affected area (morning and evening when Aedes is active)
   • IEC: Mass awareness campaigns through ASHA, ANM, Gram Panchayat - promote use of mosquito nets, repellents, long-sleeved clothing, eliminating breeding sites
6. Passive surveillance activation: Alert all ASHAs, ANMs, CHOs, and nearby PHCs to report any new fever case; increase surveillance sensitivity.
7. Laboratory support: Arrange collection of blood samples from suspected cases for dengue confirmation; send to district laboratory.
8. Case management support: Ensure adequate dengue management supplies at PHC/CHC (IV fluids, platelet test kits); refer severe cases to district hospital with proper documentation.

---

Q24. Acute Watery Diarrhoea Outbreak Investigation [IQCITY]

Definition of Outbreak

---

Steps to Investigate the Outbreak

1. Confirm the diagnosis: Verify clinical diagnosis (acute watery diarrhoea ± blood) and establish laboratory diagnosis (stool culture - Vibrio cholerae, ETEC, Shigella, Salmonella)
2. Confirm the outbreak: Check if case numbers exceed expected baseline; collect data from PHC, hospitals, ASHA reports
3. Define a case definition (e.g., "Any person in village X attending a community feast on [date] who developed ≥3 watery stools within 48 hours")
4. Case finding: Line listing of all cases - name, age, sex, address, food items eaten at feast, onset date, outcome
5. Descriptive epidemiology: Person-Place-Time analysis; calculate food-specific attack rates for each item served at feast
6. Generate hypothesis: Most likely contaminated food item at community feast → point-source outbreak
7. Test hypothesis: Analytical case-control study; collect food, water, vomitus, stool samples for laboratory analysis
8. Implement control measures (see below)

---

Epidemic Curve - Drawing and Interpretation

Cases
 10 |       ██
  8 |      ████
  6 |     ██████
  4 |    ████████
  2 |   ██████████
  0 +--+--+--+--+--+-- Time
     Day1 2  3  4  5

• The curve shows a sharp rise and rapid fall - typical of a point-source/common-source outbreak
• All cases cluster within a short time (within 1-2 incubation periods of the causative agent)
• The peak at Day 1-2 (within 48 hours) following the community feast confirms contaminated food/water at the feast as the likely source
• No secondary person-to-person spread (no secondary peak after one incubation period)

---

Control Measures

1. Case management: ORS and IV fluids for dehydrated patients; antibiotics for cholera (single dose doxycycline/tetracycline) if confirmed
2. Remove source: Identify and discard all remaining food from the feast; restrict use of suspected water source
3. Chlorination of drinking water sources

1. Safe water supply: Piped chlorinated water; periodic bacteriological testing
2. Food safety laws for community feasts (food handler certification, food inspection)
3. Sanitation: Construction of household toilets; elimination of open defecation
4. Health education: Handwashing with soap, safe food handling, boiling of water
5. Vaccine: Oral cholera vaccine (OCV) for high-risk populations if cholera is confirmed

---

Q25. Diarrhoeal Outbreak in Under-5 Children [ESIC JOKA]

Steps to Investigate the Outbreak

1. Confirm diagnosis and verify outbreak - Are cases genuinely in excess of expected? Check seasonal patterns.
2. Establish case definition: "Any child below 5 years in [block] who develops ≥3 loose stools per day between [dates]"
3. Activate rapid response: Form RRT (MO-PHC, ASHA, sanitarian, laboratory technician)
4. Case finding and line listing - house-to-house survey with ASHA support
5. Descriptive epidemiology:
   • Person: Age distribution within under-5s (peak in 6-24 months?), immunization status, nutritional status, breastfeeding history
   • Place: Which villages/wards most affected? Common water source?
   • Time: Epidemic curve - sudden or gradual onset?
6. Source identification: Check water sources (hand pumps, open wells, ponds), water quality testing (E. coli count), food practices (complementary feeding hygiene), WASH status
7. Laboratory: Stool culture from 5-10 cases; water sample analysis (total coliform, E. coli); Rotavirus antigen testing (if rapid test available)
8. Hypothesis testing: Association between exposure (water source, food type) and disease occurrence
9. Implement control measures immediately (do not wait for full investigation)
10. Report to CMOH and IDSP portal; submit RRT report within 24-48 hours

---

Four Measures to Control the Problem

1. Safe water supply: Chlorination/hypochlorination of drinking water sources; distribution of ORS and water purification tablets
2. Promotion of handwashing with soap at critical times (before feeding child, after defecation, after cleaning infant)
3. Exclusive breastfeeding promotion for <6 months; safe complementary feeding practices with ASHA support
4. Immunization: Ensure completion of Rotavirus vaccine schedule for all unvaccinated under-5 children; conduct vaccine catch-up camps

---

Vaccine in National Immunization Schedule for Diarrhoeal Disease Prevention

---

Q26. Case-Control Study: Calcium Intake and Osteoporosis [ESIC JOKA]

(a) Type of Study and Reason

1. The study starts with the outcome (osteoporosis present vs. absent) and looks backwards at the exposure (past calcium intake) - this is the hallmark of a case-control study.
2. The comparison is between cases (women with osteoporosis) and controls (women without osteoporosis)
3. It is efficient for studying an outcome (osteoporosis) that may have had its causal exposure (low calcium intake) years in the past
4. Community-based, observational, and retrospective in design

---

(b) Steps Involved

1. Define cases and controls:
   • Cases: Elderly women with confirmed osteoporosis (DXA T-score ≤ -2.5 at lumbar spine or hip), newly diagnosed, from community/hospital
   • Controls: Elderly women without osteoporosis (T-score > -2.5), same community, similar age (±5 years), matched on menopausal status and age
2. Eligibility and matching criteria:
   • Include post-menopausal women aged ≥50 years; exclude those with secondary osteoporosis (corticosteroid use, hyperparathyroidism, malabsorption), those on calcium/Vitamin D supplements (or account for this)
3. Sample size calculation: Using expected OR of 2.0, alpha = 0.05, power = 80%, proportion of controls exposed to low calcium = 30%
4. Measure exposure - dietary calcium intake:
   • Administer validated semi-quantitative food frequency questionnaire (FFQ) covering last 5-10 years (dairy products, green leafy vegetables, fish)
   • 24-hour dietary recall method (repeated on 3 non-consecutive days)
   • Calculate daily calcium intake in mg/day
   • Categorize: Adequate (≥1000 mg/day) vs. Low (<1000 mg/day) per WHO/Indian RDA
5. Measure and control confounders:
   • Collect data on: age, BMI, physical activity, sunlight exposure, Vitamin D status (serum 25-OH Vitamin D), smoking, alcohol, corticosteroid use, family history of osteoporosis, age at menopause
6. Analysis:
   • 2×2 table: Calculate Odds Ratio (OR) = (a×d)/(b×c)
   • If OR >1 with 95% CI not crossing 1 → low calcium intake significantly associated with osteoporosis
   • Multivariate logistic regression to adjust for confounders (age, BMI, Vitamin D, physical activity)
7. Interpretation: If OR is significantly >1, low calcium intake is a risk factor for osteoporosis in elderly women. Recommendations for calcium supplementation and dietary intervention follow.

---

(c) Advantages and Disadvantages

1. Efficient for studying rare or slowly-developing conditions: Osteoporosis develops over decades; a cohort study would take too long. Case-control assembles existing cases quickly.
2. Can study multiple exposures simultaneously: Besides calcium, the same study can examine Vitamin D intake, physical activity, smoking, etc. as risk factors in one study.

1. Recall bias: Cases (with osteoporosis) may recall and report their past dietary calcium intake differently (more carefully or inaccurately) than controls who have no disease. This can exaggerate or underestimate the association.
2. Cannot calculate true incidence or Relative Risk: Only the Odds Ratio is obtainable, which approximates RR only when the disease is rare (rare disease assumption).

---